Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-08 Purchase | 2024-02-12 6:23 pm | Jasper Therapeutics Inc. | JSPR | Carlyle Group Inc. Carlyle Holdings I GP Inc. Carlyle Holdings I GP Sub L.L.C. Carlyle Holdings I L.P. CG Subsidiary Holdings L.L.C. TC Group LLC Carlyle Investment Management LLC Carlyle Genesis UK LLC Abingworth LLP Abingworth Bioventures VII LP Former 10% Owner | 190,000 | $12.95 | $2,460,500 | 1,066,189 (Indirect) | View |
| 2023-01-27 Purchase | 2023-01-31 5:24 pm | Jasper Therapeutics Inc. | JSPR | Carlyle Group Inc. Abingworth LLP Carlyle Holdings I GP Inc. Carlyle Holdings I GP Sub L.L.C. Carlyle Holdings I L.P. CG Subsidiary Holdings L.L.C. TC Group LLC Carlyle Investment Management LLC Carlyle Genesis UK LLC 10% Owner | 3,133,333 | $1.5 | $4,700,000 | 8,761,891 (Indirect) | View |
| 2022-08-17 Sale | 2022-08-19 4:39 pm | Vera Therapeutics Inc. | VERA | Carlyle Group Inc. Abingworth LLP Abingworth Bioventures 8 LP Carlyle Holdings I GP Inc. Carlyle Holdings I GP Sub L.L.C. Carlyle Holdings I L.P. CG Subsidiary Holdings L.L.C. TC Group LLC Carlyle Investment Management LLC Carlyle Genesis UK LLC 10% Owner | 9,925 | $20.25 | $201,026 | 2,960,231 (Indirect) | View |
| 2022-03-29 Purchase | 2022-03-31 5:31 pm | SOLENO THERAPEUTICS INC | SLNO | Abingworth LLP 10% Owner | 7,720,000 | $0 | $0 | 25,856,994 (Indirect) | View |
| 2022-01-31 Purchase | 2022-02-01 5:00 pm | Sierra Oncology Inc. | SRRA | Abingworth LLP 10% Owner | 150,000 | $27 | $4,050,000 | 1,314,127 (Indirect) | View |
| 2021-05-18 Purchase | 2021-05-18 6:00 pm | Vera Therapeutics Inc. | VERA | Abingworth LLP 10% Owner | 772,727 | $11 | $8,499,997 | 2,970,156 (Indirect) | View |
| 2020-10-20 Sale | 2020-10-21 4:05 pm | Personalis Inc. | PSNL | Abingworth LLP Former 10% Owner | 130,486 | $27.66 | $3,609,243 | 3,753,340 (Indirect) | View |
| 2020-10-16 Sale | 2020-10-20 4:06 pm | Personalis Inc. | PSNL | Abingworth LLP 10% Owner | 290,641 | $27.48 | $7,986,081 | 3,883,826 (Indirect) | View |
| 2020-10-14 Sale | 2020-10-16 4:05 pm | Personalis Inc. | PSNL | Abingworth LLP 10% Owner | 85,625 | $27.05 | $2,315,913 | 4,174,467 (Indirect) | View |
| 2020-10-12 Sale | 2020-10-14 4:05 pm | Personalis Inc. | PSNL | Abingworth LLP 10% Owner | 202,360 | $28.81 | $5,829,352 | 4,260,092 (Indirect) | View |
| 2020-08-18 Sale | 2020-08-20 4:00 pm | Personalis Inc. | PSNL | Abingworth LLP 10% Owner | 986,842 | $19 | $18,749,998 | 4,462,452 (Indirect) | View |
| 2020-06-26 Purchase | 2020-07-06 4:02 pm | SOLENO THERAPEUTICS INC | SLNO | Abingworth LLP 10% Owner | 3,333,330 | $1.65 | $5,499,995 | 10,302,602 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-09-28 Conversion | 2023-10-02 7:54 pm | N/A N/A | SOLENO THERAPEUTICS INC | SLNO | Carlyle Group Inc. Carlyle Holdings I GP Inc. Carlyle Holdings I GP Sub L.L.C. Carlyle Holdings I L.P. CG Subsidiary Holdings L.L.C. TC Group LLC Carlyle Investment Management LLC Carlyle Genesis UK LLC Abingworth LLP Abingworth Bioventures VII LP 10% Owner | 1,092,056 | $0 | 2,293,562 (Indirect) | View |
| 2023-09-28 Conversion | 2023-10-02 7:54 pm | N/A N/A | SOLENO THERAPEUTICS INC | SLNO | Carlyle Group Inc. Carlyle Holdings I GP Inc. Carlyle Holdings I GP Sub L.L.C. Carlyle Holdings I L.P. CG Subsidiary Holdings L.L.C. TC Group LLC Carlyle Investment Management LLC Carlyle Genesis UK LLC Abingworth LLP Abingworth Bioventures VII LP 10% Owner | 1,092,056 | $1.75 | 2,293,562 (Indirect) | View |
| 2022-08-17 Exercise | 2022-08-19 4:39 pm | N/A 2031-05-12 | Vera Therapeutics Inc. | VERA | Carlyle Group Inc. Abingworth LLP Abingworth Bioventures 8 LP Carlyle Holdings I GP Inc. Carlyle Holdings I GP Sub L.L.C. Carlyle Holdings I L.P. CG Subsidiary Holdings L.L.C. TC Group LLC Carlyle Investment Management LLC Carlyle Genesis UK LLC 10% Owner | 9,925 | $0 | 2,960,231 (Indirect) | View |
| 2022-08-17 Exercise | 2022-08-19 4:39 pm | N/A N/A | Vera Therapeutics Inc. | VERA | Carlyle Group Inc. Abingworth LLP Abingworth Bioventures 8 LP Carlyle Holdings I GP Inc. Carlyle Holdings I GP Sub L.L.C. Carlyle Holdings I L.P. CG Subsidiary Holdings L.L.C. TC Group LLC Carlyle Investment Management LLC Carlyle Genesis UK LLC 10% Owner | 9,925 | $11 | 2,960,231 (Indirect) | View |
| 2018-12-21 Option Award | 2022-03-31 5:31 pm | N/A 2028-12-21 | SOLENO THERAPEUTICS INC | SLNO | Abingworth LLP 10% Owner | 114,392 | $0 | 25,856,994 (Indirect) | View |
| 2022-03-21 Option Award | 2022-03-23 5:30 pm | N/A 2032-03-21 | Jasper Therapeutics Inc. | JSPR | Abingworth LLP 10% Owner | 78,045 | $0 | 78,045 (Indirect) | View |
| 2022-01-28 Exercise | 2022-02-01 5:00 pm | N/A N/A | Sierra Oncology Inc. | SRRA | Abingworth LLP 10% Owner | 287,471 | $13.2 | 1,314,127 (Indirect) | View |
| 2022-01-28 Exercise | 2022-02-01 5:00 pm | 2020-01-22 N/A | Sierra Oncology Inc. | SRRA | Abingworth LLP 10% Owner | 287,471 | $0 | 1,314,127 (Indirect) | View |
| 2021-10-06 Option Award | 2021-12-17 4:30 pm | N/A 2031-10-05 | eFFECTOR Therapeutics Inc. | EFTR | Abingworth LLP 10% Owner | 40,000 | $0 | 40,000 (Indirect) | View |
Ownership | 2021-11-05 4:44 pm | N/A N/A | Sierra Oncology Inc. | SRRA | Abingworth LLP 10% Owner | 0 | $0 | 2,051,626 (Indirect) | View |
Ownership | 2021-10-01 4:30 pm | N/A N/A | Jasper Therapeutics Inc. | JSPR | Abingworth LLP 10% Owner | 0 | $0 | 5,628,558 (Indirect) | View |
Ownership | 2021-08-27 6:31 pm | N/A N/A | eFFECTOR Therapeutics Inc. | EFTR | Abingworth LLP 10% Owner | 0 | $0 | 5,427,452 (Indirect) | View |
| 2021-05-18 Conversion | 2021-05-18 6:00 pm | N/A N/A | Vera Therapeutics Inc. | VERA | Abingworth LLP 10% Owner | 2,187,504 | $0 | 2,970,156 (Indirect) | View |
| 2021-05-13 Option Award | 2021-05-18 6:00 pm | N/A 2031-05-12 | Vera Therapeutics Inc. | VERA | Abingworth LLP 10% Owner | 9,925 | $0 | 2,970,156 (Indirect) | View |
Ownership | 2021-05-13 7:28 pm | N/A N/A | Vera Therapeutics Inc. | VERA | Abingworth LLP 10% Owner | 0 | $0 | 2,187,504 (Indirect) | View |
| 2020-06-11 Option Award(A) | 2020-06-16 6:26 pm | N/A 2030-06-10 | Vaxcyte Inc. | PCVX | Abingworth LLP 10% Owner | 40,000 | $0 | 40,000 (Indirect) | View |
| 2020-06-11 Option Award | 2020-06-15 4:41 pm | N/A 2030-06-10 | Vaxcyte Inc. | PCVX | Abingworth LLP 10% Owner | 40,000 | $0 | 40,000 (Indirect) | View |
Ownership | 2020-06-11 8:52 pm | N/A N/A | Vaxcyte Inc. | PCVX | Abingworth LLP 10% Owner | 0 | $0 | 4,156,218 (Indirect) | View |